Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study

Mateos M., Rodriguez Otero P., Koh Y., Martinez-Lopez J., Parmar G., Prince H. M., ...More

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, pp.7317-7319

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1182/blood-2022-157302
  • City: Louisiana
  • Country: United States Of America
  • Page Numbers: pp.7317-7319
  • Istanbul University Affiliated: No